Today's special offer: Access for Free!!!

Profile
Financial Statement
- Income Statement
- Comprehensive Income
- Assets
- Liabilities and Stockholders' Equity
- Statement of Cash Flows
Common-Size
- Income Statement
- Assets
- Liabilities and Stockholders' Equity
Ratios
- Short-term Activity
- Long-term Activity
- Liquidity
- Long-term Debt and Solvency
- Profitability
- DuPont
Relative Valuation
- Ratios (Price Multiples)
- Enterprise Value (EV)
- EV to EBITDA
- EV to FCFF
- Price to FCFE
DCF
- CAPM
- DDM
- Present Value of FCFF
- Present Value of FCFE
Analysis
- Revenues
- Investments
- Inventory
- Property, Plant and Equipment
- Goodwill and Intangible Assets
- Debt
Reporting Quality
- Aggregate Accruals

Abbott Laboratories (ABT) | Common-Size Income Statement

See also

Johnson & Johnson (JNJ), Common-Size Income Statement
Pfizer Inc. (PFE), Common-Size Income Statement
Novartis AG (NVS), Common-Size Income Statement
Merck & Co. Inc. (MRK), Common-Size Income Statement
GlaxoSmithKline PLC (GSK), Common-Size Income Statement
Sanofi (SNY), Common-Size Income Statement
Novo Nordisk A/S (NVO), Common-Size Income Statement
UnitedHealth Group Inc. (UNH), Common-Size Income Statement
Bristol-Myers Squibb Co. (BMY), Common-Size Income Statement
AstraZeneca PLC (AZN), Common-Size Income Statement
Eli Lilly & Co. (LLY), Common-Size Income Statement
Medtronic Inc. (MDT), Common-Size Income Statement
Baxter International Inc. (BAX), Common-Size Income Statement

ˇ Show More

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Abbott Laboratories, Common-Size Consolidated Income Statement

Export to Excel

Export to OpenOffice.org

		Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
	Net sales
	Cost of products sold
	Gross profit	%	%	%	%	%
	Research and development
	Acquired in-process and collaborations research and development
	Selling, general and administrative
	Operating earnings	%	%	%	%	%
	Interest expense
	Interest income
	Income from the TAP Pharmaceutical Products Inc. joint venture
	Net foreign exchange gain (loss)
	Other income (expense), net
	Earnings from continuing operations before taxes	%	%	%	%	%
	Taxes on earnings
	Earnings from continuing operations	%	%	%	%	%
	Gain on sale of discontinued operations, net of taxes
	Net earnings	%	%	%	%	%

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center